top of page
We Are Your Contract Commercial Team
We are a specialized outsourced sales and business development organization dedicated to accelerating commercial success for companies in the cell and gene therapy market.
Our team combines deep industry expertise with proven sales strategies to bridge the gap between groundbreaking science and market adoption and sales.
Susan Nichols
Founder
Susan Nichols is the CEO of Propel Biosciences and a 30-year veteran of the biotechnology industry, with a career spanning diagnostics, cell and gene therapy, and life science tools and services.
Her journey into biotech was born from personal experience — a brother with a rare disease who spent years misdiagnosed. That early exposure sparked a lifelong belief in the power of science to bring clarity and change lives.
Susan began her career in diagnostics, leading regional sales, national training, marketing, and new product launches in mature, highly competitive markets. There, she mastered the commercialization fundamentals that turn innovation into adoption.
Today, she brings that strategic rigor to the emerging biotech landscape — helping CGT and high-science companies navigate the commercialization gap with clarity, discipline, and urgency.
Susan has served as CEO of a genetically modified cell therapy company and CBO of a global viral vector CDMO. She’s held executive roles at industry leaders including Invetech/Danaher, Thermo Fisher/ASI, Hitachi Chemical, and Roche Diagnostics, and has driven commercial growth across CDMO, engineering services, drug development, and manufacturing technologies.
She is a respected leader in the regenerative medicine space, sits on the Board of Directors for the Alliance for Regenerative Medicine, and is a passionate advocate for patient-driven innovation, diversity in biotech leadership, and the success of early-stage life science ventures.
From funding to partnerships, from startup to scale, Susan brings the depth, network, and executional excellence to drive biotech innovation forward — all the way to market success.
Angie Higdon
Director of Marketing
As Director of Marketing at Propel Biosciences, Angie drives brand strategy, market clarity, and go-to-market execution for clients across cell and gene therapy, diagnostics, and biotech-enabling technologies. Known for bringing simplicity to complexity, Angie blends deep industry insight with operational rigor to position both Propel and its clients for sustained commercial growth in science-first markets.
With a strong foundation in global brand development, cross-functional leadership, and strategic implementation, Angie builds scalable systems, aligns multidisciplinary teams, and transforms strategy into action. As both a mentor and facilitator, she ensures every message lands, every launch aligns, and every team is equipped to deliver — helping scientific innovators communicate with clarity and compete with confidence.
Consultants:Propel Biosciences is more than a single voice — it’s a collective of senior business development and sales consultants who have led commercialization efforts across top-tier biotech, CGT, and life science organizations. Our extended team brings decades of in-field experience, spanning BD strategy, enterprise sales, and global market expansion. While we keep our collaborators and client relationships confidential, our impact is clear: we operate as an embedded growth engine, equipping scientific innovators with the commercial power they need — without the overhead or risk of hiring before they're ready.
bottom of page